Population Pharmacokinetics of Polymyxin B in Obese Patients for Resistant Gram-Negative Infections
Polymyxin B is an effective but potentially nephrotoxic antibiotic that is commonly used to treat resistant Gram-negative infections. As a weight-based dosing drug, obese patients may be at a high risk of nephrotoxicity. However, the pharmacokinetics and dosing recommendations for this population ar...
Guardado en:
Autores principales: | Peile Wang, Qiwen Zhang, Min Feng, Tongwen Sun, Jing Yang, Xiaojian Zhang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/54b12a7c1f4344fabe5c1431ad764201 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Assessment of Micafungin Dosage Regimens in Patients with Cancer Using Pharmacokinetic/Pharmacodynamic Modeling and Monte Carlo Simulation
por: Saeed Alqahtani, et al.
Publicado: (2021) -
The Monte Carlo Simulation of Three Antimicrobials for Empiric Treatment of Adult Bloodstream Infections With Carbapenem-Resistant Enterobacterales in China
por: Dongna Zou, et al.
Publicado: (2021) -
Polymyxin E–Resistant Gram-Negative Bacteria in Tunisia and Neighboring Countries: Are There Commonalities?
por: Dziri O, et al.
Publicado: (2021) -
Population Pharmacokinetic Analysis and Dosing Optimization of Prophylactic Fluconazole in Japanese Patients with Hematological Malignancy
por: Yasutaka Sakamoto, et al.
Publicado: (2021) -
Population Pharmacokinetics of Meropenem in Critically Ill Korean Patients and Effects of Extracorporeal Membrane Oxygenation
por: Dong-Hwan Lee, et al.
Publicado: (2021)